PREDICTIVE TECHNOLOGY GROUP ANNOUNCES LAUNCH OF PGxPLUS+™ PHARMACOGENOMIC TEST AND REACHES CLINICAL STUDY ENROLLMENT MILESTONE

By |2019-08-09T11:56:39-06:00August 9th, 2019|

PREDICTIVE TECHNOLOGY GROUP ANNOUNCES LAUNCH OF PGxPLUS+™ PHARMACOGENOMIC TEST AND REACHES CLINICAL STUDY ENROLLMENT MILESTONE Enrollment reaches 350 patients for IRB-approved study focused on chronic pain SALT LAKE CITY (August 9, 2019) –Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent clinical intervention through [...]